Celgene Corp Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CELGENE CORP, and when can generic versions of CELGENE CORP drugs launch?
CELGENE CORP has two approved drugs.
There are seven US patents protecting CELGENE CORP drugs.
There are one hundred and sixty-four patent family members on CELGENE CORP drugs in forty countries.
Summary for Celgene Corp
| International Patents: | 164 |
| US Patents: | 7 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
| Drug Master File Entries: | 4 |
| Patent Litigation for Celgene Corp: | See patent lawsuits for Celgene Corp |
| PTAB Cases with Celgene Corp as patent owner: | See PTAB cases with Celgene Corp as patent owner |
Drugs and US Patents for Celgene Corp
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Celgene Corp | ONUREG | azacitidine | TABLET;ORAL | 214120-001 | Sep 1, 2020 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | |||||
| Celgene Corp | IDHIFA | enasidenib mesylate | TABLET;ORAL | 209606-001 | Aug 1, 2017 | RX | Yes | No | 10,610,125 | See Plans and Pricing | See Plans and Pricing | ||||
| Celgene Corp | ONUREG | azacitidine | TABLET;ORAL | 214120-002 | Sep 1, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | |||||
| Celgene Corp | ONUREG | azacitidine | TABLET;ORAL | 214120-001 | Sep 1, 2020 | RX | Yes | No | 8,846,628 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Celgene Corp | IDHIFA | enasidenib mesylate | TABLET;ORAL | 209606-002 | Aug 1, 2017 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Celgene Corp Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2021176893 | See Plans and Pricing |
| Japan | 2017137326 | See Plans and Pricing |
| European Patent Office | 3566706 | See Plans and Pricing |
| Japan | 2019142930 | See Plans and Pricing |
| Australia | 2018247242 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
